drugset / Trial / NCT07728097

A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS

NCT07728097 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is a Phase 3b/Phase 4 study. The purpose of this study is to learn more about the efficacy of using CBD-OS as an add-on therapy for the treatment of LGS in adults.

Timeline

Start
2026-11-18
Primary completion
2028-12-28
Completion
2028-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 20 mg/kg Oral